JP2000507226A5 - - Google Patents

Download PDF

Info

Publication number
JP2000507226A5
JP2000507226A5 JP1997532077A JP53207797A JP2000507226A5 JP 2000507226 A5 JP2000507226 A5 JP 2000507226A5 JP 1997532077 A JP1997532077 A JP 1997532077A JP 53207797 A JP53207797 A JP 53207797A JP 2000507226 A5 JP2000507226 A5 JP 2000507226A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP1997532077A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000507226A (ja
Filing date
Publication date
Priority claimed from GBGB9606452.2A external-priority patent/GB9606452D0/en
Application filed filed Critical
Publication of JP2000507226A publication Critical patent/JP2000507226A/ja
Publication of JP2000507226A5 publication Critical patent/JP2000507226A5/ja
Withdrawn legal-status Critical Current

Links

JP9532077A 1996-03-27 1997-03-26 血管疾病および異種移植におけるラパマイシン誘導体の使用 Withdrawn JP2000507226A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9606452.2 1996-03-27
GBGB9606452.2A GB9606452D0 (en) 1996-03-27 1996-03-27 Organic compounds
PCT/EP1997/001548 WO1997035575A1 (en) 1996-03-27 1997-03-26 Use of rapamycin derivatives in vasculopathies and xenotransplantation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008314494A Division JP5124431B2 (ja) 1996-03-27 2008-12-10 血管疾病および異種移植におけるラパマイシン誘導体の使用

Publications (2)

Publication Number Publication Date
JP2000507226A JP2000507226A (ja) 2000-06-13
JP2000507226A5 true JP2000507226A5 (show.php) 2004-12-02

Family

ID=10791127

Family Applications (2)

Application Number Title Priority Date Filing Date
JP9532077A Withdrawn JP2000507226A (ja) 1996-03-27 1997-03-26 血管疾病および異種移植におけるラパマイシン誘導体の使用
JP2008314494A Expired - Lifetime JP5124431B2 (ja) 1996-03-27 2008-12-10 血管疾病および異種移植におけるラパマイシン誘導体の使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008314494A Expired - Lifetime JP5124431B2 (ja) 1996-03-27 2008-12-10 血管疾病および異種移植におけるラパマイシン誘導体の使用

Country Status (29)

Country Link
US (5) US6384046B1 (show.php)
EP (3) EP2008657B1 (show.php)
JP (2) JP2000507226A (show.php)
KR (2) KR20070083654A (show.php)
CN (1) CN1124135C (show.php)
AT (1) ATE224194T1 (show.php)
AU (1) AU716514B2 (show.php)
BR (1) BR9708358A (show.php)
CA (1) CA2247275C (show.php)
CY (1) CY2404B1 (show.php)
CZ (1) CZ292483B6 (show.php)
DE (1) DE69715611T2 (show.php)
DK (2) DK2008657T3 (show.php)
ES (2) ES2421455T3 (show.php)
GB (1) GB9606452D0 (show.php)
HU (1) HU226422B1 (show.php)
ID (1) ID17195A (show.php)
IL (1) IL125812A (show.php)
MY (1) MY117798A (show.php)
NO (1) NO316667B1 (show.php)
NZ (1) NZ331463A (show.php)
PL (1) PL187732B1 (show.php)
PT (2) PT2008657E (show.php)
RU (1) RU2214247C2 (show.php)
SI (1) SI2008657T1 (show.php)
SK (1) SK284343B6 (show.php)
TR (1) TR199801919T2 (show.php)
WO (1) WO1997035575A1 (show.php)
ZA (1) ZA972719B (show.php)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9606452D0 (en) * 1996-03-27 1996-06-05 Sandoz Ltd Organic compounds
CA2261666C (en) 1996-07-30 2010-09-14 Novartis Ag Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxiethyl)-rapamycin
US20030129215A1 (en) * 1998-09-24 2003-07-10 T-Ram, Inc. Medical devices containing rapamycin analogs
US6890546B2 (en) 1998-09-24 2005-05-10 Abbott Laboratories Medical devices containing rapamycin analogs
WO2000067773A2 (en) 1999-05-10 2000-11-16 Novartis Ag Combinations of immunosupressive agents for the treatment or prevention of graft rejections
US7807211B2 (en) 1999-09-03 2010-10-05 Advanced Cardiovascular Systems, Inc. Thermal treatment of an implantable medical device
US6790228B2 (en) 1999-12-23 2004-09-14 Advanced Cardiovascular Systems, Inc. Coating for implantable devices and a method of forming the same
US20070032853A1 (en) 2002-03-27 2007-02-08 Hossainy Syed F 40-O-(2-hydroxy)ethyl-rapamycin coated stent
US8088060B2 (en) 2000-03-15 2012-01-03 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
US20070055367A1 (en) * 2000-03-15 2007-03-08 Orbus Medical Technologies, Inc. Medical device with coating that promotes endothelial cell adherence and differentiation
US20030229393A1 (en) * 2001-03-15 2003-12-11 Kutryk Michael J. B. Medical device with coating that promotes cell adherence and differentiation
US8460367B2 (en) * 2000-03-15 2013-06-11 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
US20070141107A1 (en) * 2000-03-15 2007-06-21 Orbusneich Medical, Inc. Progenitor Endothelial Cell Capturing with a Drug Eluting Implantable Medical Device
AU2001245734A1 (en) 2000-03-15 2001-09-24 Orbus Medical Technologies Inc. Coating that promotes endothelial cell adherence
US9522217B2 (en) 2000-03-15 2016-12-20 Orbusneich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods for using same
US7300662B2 (en) 2000-05-12 2007-11-27 Cordis Corporation Drug/drug delivery systems for the prevention and treatment of vascular disease
US20050002986A1 (en) * 2000-05-12 2005-01-06 Robert Falotico Drug/drug delivery systems for the prevention and treatment of vascular disease
US8236048B2 (en) 2000-05-12 2012-08-07 Cordis Corporation Drug/drug delivery systems for the prevention and treatment of vascular disease
EP1709974A3 (en) * 2000-06-16 2006-12-06 Wyeth Method of treating cardiovascular disease using rapamycin
US6670355B2 (en) 2000-06-16 2003-12-30 Wyeth Method of treating cardiovascular disease
US20020013335A1 (en) * 2000-06-16 2002-01-31 American Home Products Corporation Method of treating cardiovascular disease
US8303609B2 (en) 2000-09-29 2012-11-06 Cordis Corporation Coated medical devices
ES2640787T3 (es) 2001-02-19 2017-11-06 Novartis Ag Combinación de un derivado de rapamicina y letrozol para tratar el cáncer de mama
US8741378B1 (en) 2001-06-27 2014-06-03 Advanced Cardiovascular Systems, Inc. Methods of coating an implantable device
US7682387B2 (en) 2002-04-24 2010-03-23 Biosensors International Group, Ltd. Drug-delivery endovascular stent and method for treating restenosis
US6939376B2 (en) 2001-11-05 2005-09-06 Sun Biomedical, Ltd. Drug-delivery endovascular stent and method for treating restenosis
KR20050004785A (ko) * 2002-02-22 2005-01-12 프롭휘 메드 아베 조직 인자의 억제제 또는 길항제의 용도
US20040024450A1 (en) * 2002-04-24 2004-02-05 Sun Biomedical, Ltd. Drug-delivery endovascular stent and method for treating restenosis
AU2003241515A1 (en) * 2002-05-20 2003-12-12 Orbus Medical Technologies Inc. Drug eluting implantable medical device
US8109987B2 (en) 2003-04-14 2012-02-07 Tryton Medical, Inc. Method of treating a lumenal bifurcation
US7279174B2 (en) 2003-05-08 2007-10-09 Advanced Cardiovascular Systems, Inc. Stent coatings comprising hydrophilic additives
US20050118344A1 (en) 2003-12-01 2005-06-02 Pacetti Stephen D. Temperature controlled crimping
US7220755B2 (en) 2003-11-12 2007-05-22 Biosensors International Group, Ltd. 42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same
US9114198B2 (en) 2003-11-19 2015-08-25 Advanced Cardiovascular Systems, Inc. Biologically beneficial coatings for implantable devices containing fluorinated polymers and methods for fabricating the same
EP2946666B1 (en) * 2004-04-30 2017-11-15 OrbusNeich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods of using same
US20110104186A1 (en) 2004-06-24 2011-05-05 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
US8709469B2 (en) 2004-06-30 2014-04-29 Abbott Cardiovascular Systems Inc. Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device
US7901451B2 (en) 2004-09-24 2011-03-08 Biosensors International Group, Ltd. Drug-delivery endovascular stent and method for treating restenosis
EP1838288A4 (en) * 2004-12-20 2010-08-04 Ariad Pharma Inc THERAPEUTIC MATERIALS AND METHODS
EP1962839A4 (en) 2005-11-14 2010-08-25 Ariad Pharma Inc ADMINISTRATION OF A MNTOR INHIBITOR FOR THE TREATMENT OF PATIENTS WITH CANCER
US20080317814A1 (en) * 2005-11-17 2008-12-25 Access Plus Co., Ltd. Tube for Connecting Marteriovenous and Interposition for Medical Operation
US20070173923A1 (en) * 2006-01-20 2007-07-26 Savage Douglas R Drug reservoir stent
CN101557814B (zh) 2006-09-13 2015-05-20 万能医药公司 大环内酯化合物及它们的使用方法
US8067055B2 (en) * 2006-10-20 2011-11-29 Biosensors International Group, Ltd. Drug-delivery endovascular stent and method of use
US20080097591A1 (en) 2006-10-20 2008-04-24 Biosensors International Group Drug-delivery endovascular stent and method of use
US20080103584A1 (en) 2006-10-25 2008-05-01 Biosensors International Group Temporal Intraluminal Stent, Methods of Making and Using
KR100930167B1 (ko) * 2007-09-19 2009-12-07 삼성전기주식회사 초광각 광학계
US8661630B2 (en) 2008-05-21 2014-03-04 Abbott Cardiovascular Systems Inc. Coating comprising an amorphous primer layer and a semi-crystalline reservoir layer
AU2008322469B2 (en) 2007-11-14 2014-02-20 Biosensors International Group, Ltd. Automated coating apparatus and method
US8921642B2 (en) * 2008-01-11 2014-12-30 Massachusetts Eye And Ear Infirmary Conditional-stop dimerizable caspase transgenic animals
JP2012504654A (ja) * 2008-10-03 2012-02-23 エリクシアー メディカル コーポレイション 多環状ラクトン化合物およびその使用方法
US8366763B2 (en) 2009-07-02 2013-02-05 Tryton Medical, Inc. Ostium support for treating vascular bifurcations
US8685433B2 (en) 2010-03-31 2014-04-01 Abbott Cardiovascular Systems Inc. Absorbable coating for implantable device
UA104738C2 (ru) 2011-05-18 2014-03-11 Олег Миколайович Лазаренко Композиция для повышения биосовместимости имплантатов и клеток для трансплантации с организмом реципиента и способ ее приготовления
CN102268015B (zh) * 2011-08-30 2013-08-28 成都摩尔生物医药有限公司 一种依维莫司的合成方法
US10682415B2 (en) 2013-07-22 2020-06-16 Wisconsin Alumni Research Foundation Thermogel formulation for combination drug delivery
KR101723265B1 (ko) 2013-08-16 2017-04-04 가톨릭대학교 산학협력단 mTOR/STAT3 신호억제제 처리된 면역조절능을 갖는 간엽줄기세포 및 이를 포함하는 면역질환의 예방 또는 치료용 세포치료제 조성물
CA2924681C (en) 2013-09-24 2019-12-31 Giner, Inc. System for gas treatment of a cell implant
RU2707285C2 (ru) 2013-10-08 2019-11-26 ЭйАй ТЕРАПЬЮТИКС, ИНК. Рапамицин для лечения лимфангиолейомиоматоза
US10307371B2 (en) 2014-02-11 2019-06-04 AI Therapeutics, Inc. Rapamycin for the treatment of lymphangioleiomyomatosis
CN106573067A (zh) 2014-02-11 2017-04-19 拉姆医疗公司 用于淋巴管平滑肌瘤病治疗的雷帕霉素
RU2718583C2 (ru) 2014-04-04 2020-04-08 ЭйАй ТЕРАПЬЮТИКС, ИНК. Рапамицин-содержащая композиция, вводимая путем ингаляции для лечения возрастных заболеваний
US20170304276A1 (en) 2014-10-07 2017-10-26 Lam Therapeutics, Inc. An inhalable rapamycin formulation for the treatment of pulmonary hypertension
MA40910A (fr) 2014-11-07 2017-09-12 Civitas Therapeutics Inc Poudres de rapamycine pour administration pulmonaire
WO2016130645A1 (en) 2015-02-10 2016-08-18 Lam Therapeutics, Inc. Rapamycin for the treatment of lymphangioleiomyomatosis
JP2019527711A (ja) 2016-08-10 2019-10-03 ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム 局所ラパマイシン療法
KR102459201B1 (ko) 2016-09-19 2022-10-27 바이오트로닉 아게 고분자-없는 약물 용출 혈관 스텐트
KR20190086489A (ko) 2016-11-15 2019-07-22 기너 라이프 사이언시즈, 인크. 피하 임플란트와 함께 이용하기에 적합한 경피 가스 확산 장치
WO2018114992A1 (en) 2016-12-22 2018-06-28 Biotronik Ag Drug releasing coatings for medical devices and methods of making same
US11642501B2 (en) 2017-05-04 2023-05-09 Giner, Inc. Robust, implantable gas delivery device and methods, systems and devices including same
AR112834A1 (es) 2017-09-26 2019-12-18 Novartis Ag Derivados de rapamicina
WO2020128861A1 (en) 2018-12-18 2020-06-25 Novartis Ag Rapamycin derivatives
TW202045165A (zh) 2019-02-20 2020-12-16 美商Ai治療公司 局部雷帕黴素調配物以及其於治療臉部血管纖維瘤和其他皮膚疾病中的用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639724A (en) * 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
US5364612A (en) * 1991-05-06 1994-11-15 Immunomedics, Inc. Detection of cardiovascular lesions
IL102414A (en) * 1991-07-25 1996-08-04 Univ Louisville Res Found Medicinal preparations for the treatment of ocular inflammation, containing rapamycin
CA2086642C (en) * 1992-01-09 2004-06-15 Randall E. Morris Method of treating hyperproliferative vascular disease
US5516781A (en) * 1992-01-09 1996-05-14 American Home Products Corporation Method of treating restenosis with rapamycin
CA2094858C (en) * 1992-04-28 2004-06-15 Robert D. Mitchell Method of treating hyperproliferative vascular disease
US5747034A (en) * 1992-07-09 1998-05-05 Chiron Corporation Methods and materials for the induction of T cell anergy
US5283257A (en) * 1992-07-10 1994-02-01 The Board Of Trustees Of The Leland Stanford Junior University Method of treating hyperproliferative vascular disease
GB9221220D0 (en) * 1992-10-09 1992-11-25 Sandoz Ag Organic componds
ATE191218T1 (de) * 1993-12-17 2000-04-15 Novartis Ag Rapamycin-derivate als immunosuppressoren
US5362718A (en) * 1994-04-18 1994-11-08 American Home Products Corporation Rapamycin hydroxyesters
US6265427B1 (en) * 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
ES2187660T3 (es) * 1995-06-09 2003-06-16 Novartis Ag Derivados de rapamicina.
GB9606452D0 (en) * 1996-03-27 1996-06-05 Sandoz Ltd Organic compounds

Similar Documents

Publication Publication Date Title
JP2000506916A5 (show.php)
JP2000501018A5 (show.php)
JP2000500076A5 (show.php)
JP2000501324A5 (show.php)
JP2000515493A5 (show.php)
JP2000500055A5 (show.php)
JP2000500026A5 (show.php)
JP2001505191A5 (show.php)
JP2000502472A5 (show.php)
JP2000501338A5 (show.php)
JP2000500874A5 (show.php)
JP2000502485A5 (show.php)
JP2000502425A5 (show.php)
JP2000502568A5 (show.php)
JP2000500912A5 (show.php)
JP2000502570A5 (show.php)
JP2000517174A5 (show.php)
JP2000511663A5 (show.php)
JP2001513063A5 (show.php)
JP2001503400A5 (show.php)
JP2000512483A5 (show.php)
JP2001512348A5 (show.php)
JP2000501229A5 (show.php)
JP2000502316A5 (show.php)
JP2000502714A5 (show.php)